HNB
NKTR icon

Huntington National Bank’s Nektar Therapeutics NKTR Stock Holding History

Huntington National Bank’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 4082
2025
Q4 		$1 Hold
1
– – ﹤0.01% 3989
2025
Q3 		$1 Hold
1
– – ﹤0.01% 4016
2025
Q2 		$1 Buy
+1
New +$11 ﹤0.01% 4022
2025
Q1 		– Hold
0
– – – 4037
2024
Q4 		– Hold
0
– – – 4031
2024
Q3 		– Hold
0
– – – 4025
2024
Q2 		– Hold
0
– – – 3974
2024
Q1 		– Hold
0
– – – 3843
2023
Q4 		– Hold
0
– – – 3741
2023
Q3 		– Hold
0
– – – 3712
2023
Q2 		– Hold
0
– – – 3659
2023
Q1 		– Hold
0
– – – 3530
2022
Q4 		– Hold
0
– – – 3352
2022
Q3 		– Hold
0
– – – 2263
2022
Q2 		– Hold
0
– – – 2290
2022
Q1 		– Hold
0
– – – 2252
2021
Q4 		– Hold
0
– – – 2207
2021
Q3 		– Hold
0
– – – 1948
2021
Q2 		– Hold
0
– – – 1862
2021
Q1 		– Hold
0
– – – 1752
2020
Q4 		– Hold
0
– – – 1716
2020
Q3 		– Hold
0
– – – 1674
2020
Q2 		– Hold
0
– – – 1668
2020
Q1 		– Sell
-55
Closed -$17K – 1732
2019
Q4 		$18K Buy
55
+15
+38% +$4.35K ﹤0.01% 1279
2019
Q3 		$11K Buy
+40
New +$14.7K ﹤0.01% 1270
2019
Q2 		– Hold
0
– – – 1726

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Huntington National Bank's NKTR Position: Q1 2026 in Review

Huntington National Bank held its Nektar Therapeutics (NKTR) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #4082.

Huntington National Bank first reported a position in NKTR in Q3 2019 and has held it in 6 quarters since. The position peaked at $18K in Q4 2019. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Huntington National Bank held 1 share of Nektar Therapeutics worth $1 as of Q1 2026.
  • Huntington National Bank left its Nektar Therapeutics share count unchanged in Q1 2026.
  • Nektar Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4082 holding.
  • Huntington National Bank first reported a position in Nektar Therapeutics in Q3 2019 and has held it in 6 quarters since.
  • Huntington National Bank's Nektar Therapeutics position peaked at $18K in Q4 2019.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.